Upregulation of hypoxia-inducible factor (HIF)-1α and HIF-2α in leptomeningeal vascular malformations of Sturge-Weber Syndrome

Journal of Neuropathology and Experimental Neurology

Volumn 66, Issue 1, 2007, Pages 86-97

  Comati, Amina ^a   Beck, Heike ^a,d   Halliday, William ^b   Snipes, G Jackson ^c   Plate, Karl Heinz ^a   Acker, Till ^a,e  

^a Edinger Institute   (Germany)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

^e Institute of Neurology   (Germany)

Author keywords

Angiogenesis; Cerebral ischemia; Hypoxia inducible factor (HIF); Sturge Weber Syndrome; Vascular endothelial growth factor (VEGF); Vascular malformation

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN RECEPTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; NEUROPILIN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ADULT; ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFANT; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STURGE WEBER SYNDROME; UPREGULATION;

ADOLESCENT; ADULT; ANGIOGENIC PROTEINS; BLOOD VESSELS; CHILD; CHILD, PRESCHOOL; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; MALE; MENINGES; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; MODELS, BIOLOGICAL; NEUROPILINS; STURGE-WEBER SYNDROME; TRANSCRIPTION FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846078395     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/nen.0b013e31802d9011     Document Type: Article

References (54)

1. Comi AM. Pathophysiology of Sturge-Weber syndrome. J Child Neurol 2003;18:509-16
2. Breugem CC, Alders M, Salieb-Beugelaar GB, et al. A locus for hereditary capillary malformations mapped on chromosome 5q. Hum Genet 2002;110:343-47
3. Thomas-Sohl KA, Vaslow DF, Maria BL. Sturge-Weber syndrome: A review. Pediatr Neurol 2004;30:303-10
4. Duncan DB, Herholz K, Pietrzyk U, et al. Regional cerebral blood flow and metabolism in Sturge-Weber disease. Clin Nucl Med 1995;20:522-523
5. Lee JS, Asano E, Muzik O, et al. Sturge-Weber syndrome: Correlation between clinical course and FDG PET findings. Neurology 2001;57:189-95
6. Yancopoulos GD, Davis S, Gale NW, et al. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-48
7. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996;380:439-42
8. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996;380:435-39
9. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995;376:62-66
10. Kawasaki T, Kitsukawa T, Bekku Y, et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999;126:4895-902
11. Soker S, Takashima S, Miao HQ, et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 1998;92:735-45
12. Sato TN, Tozawa Y, Deutsch U, et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376:70-74
13. Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev 2001;11:293-99
14. Acker T, Plate KH. A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology. J Mol Med 2002;80:562-75
15. Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 1998;17:3005-15
16. Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 1998;12:149-62
17. Maltepe E, Schmidt JV, Baunoch D, et al. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997;386:403-7
18. Gerber HP, Condorelli F, Park J, et al. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 1997;272:23659-67
19. Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997;11:72-82
20. Favier J, Kempf H, Corvol P, et al. Coexpression of endothelial PAS protein 1 with essential angiogenic factors suggests its involvement in human vascular development. Dev Dyn 2001;222:377-88
21. Elvert G, Kappel A, Heidenreich R, et al. Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 2003;278:7520-30
22. Merrill MJ, Oldfield EH. A reassessment of vascular endothelial growth factor in central nervous system pathology. J Neurosurg 2005;103:853-68
23. Hashimoto T, Wu Y, Lawton MT, et al. Coexpression of angiogenic factors in brain arteriovenous malformations. Neurosurgery 2005;56:1058-65
24. Beck H, Acker T, Wiessner C, et al. Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat. Am J Pathol 2000;157:1473-83
25. Plate KH, Breier G, Weich HA, et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-48
26. Vogel J, Horner C, Haller C, et al. Heterologous expression of human VEGF165 in rat brain: Dose-dependent, heterogeneous effects on CBF in relation to vascular density and cross-sectional area. J Cereb Blood Flow Metab 2003;23:423-31
27. Stiver SI, Tan X, Brown LF, et al. VEGF-A angiogenesis induces a stable neovasculature in adult murine brain. J Neuropathol Exp Neurol 2004;63:841-55
28. Rosenstein JM, Mani N, Silverman WF, et al. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA 1998;95:7086-91
29. Harrigan MR, Ennis SR, Masada T, et al. Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery 2002;50:589-98
30. Rothbart D, Awad IA, Lee J, et al. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. Neurosurgery 1996;38:915-24
31. Koizumi T, Shiraishi T, Hagihara N, et al. Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. Neurosurgery 2002;50:117-24
32. Kilic T, Pamir MN, Kullu S, et al. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 2000;46:1179-91
33. Sperner J, Schmauser I, Bittner R, et al. MR-imaging findings in children with Sturge-Weber syndrome. Neuropediatrics 1990;21:146-52
34. Marti-Bonmati L, Menor F, Mulas F. The Sturge-Weber syndrome: Correlation between the clinical status and radiological CT and MRI findings. Childs Nerv Syst 1993;9:107-9
35. Irikura K, Morii S, Miyasaka Y, et al. Impaired autoregulation in an experimental model of chronic cerebral hypoperfusion in rats. Stroke 1996;27:1399-404
36. Sure U, Butz N, Schlegel J, et al. Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg 2001;94:972-77
37. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000;407:249-57
38. Maria BL, Neufeld JA, Rosainz LC, et al. Central nervous system structure and function in Sturge-Weber syndrome: Evidence of neurologic and radiologic progression. J Child Neurol 1998;13:606-18
39. Acker T, Beck H, Plate KH. Cell type specific expression of vascular endothelial growth factor and angiopoietin-1 and-2 suggests an important role of astrocytes in cerebellar vascularization. Mech Dev 2001;108:45-57
40. Uranishi R, Baev NI, Ng PY, et al. Expression of endothelial cell angiogenesis receptors in human cerebrovascular malformations. Neurosurgery 2001;48:359-67
41. Brusselmans K, Bono F, Collen D, et al. A novel role for vascular endothelial growth factor as an autocrine survival factor for embryonic stem cells during hypoxia. J Biol Chem 2005;280:3493-99
42. Li J, Post M, Volk R, et al. PR39, a peptide regulator of angiogenesis. Nat Med 2000;6:49-55
43. Tang N, Wang L, Esko J, et al. Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis. Cancer Cell 2004;6:485-95
44. Licht AH, Muller-Holtkamp F, Flamme I, et al. Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development. Blood 2006;107:584-90
45. Kimura H, Braun RD, Ong ET, et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 1996;56:5522-28
46. Sure U, Freman S, Bozinov O, et al. Biological activity of adult cavernous malformations: a study of 56 patients. J Neurosurg 2005;102:342-47
47. Bilton RL, Booker GW. The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur J Biochem 2003;270:791-98
48. Feldser D, Agani F, Iyer NV, et al. Reciprocal positive regulation of hypoxia-inducible factor 1alpha and insulin-like growth factor 2. Cancer Res 1999;59:3915-18
49. Tomlinson IP, Alam NA, Rowan AJ, et al. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 2002;30:406-10
50. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 2000;287:848-51
51. Selak MA, Armour SM, MacKenzie ED, et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 2005;7:77-85
52. Isaacs JS, Jung YJ, Mole DR, et al. HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: Novel role of fumarate in regulation of HIF stability. Cancer Cell 2005;8:143-53
53. Tang N, Mack F, Haase VH, et al. pVHL function is essential for endothelial extracellular matrix deposition. Mol Cell Biol 2006;26:2519-30
54. Comi AM, Weisz CJ, Highet BH, et al. Sturge-Weber syndrome: Altered blood vessel fibronectin expression and morphology. J Child Neurol 2005;20:572-77